Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

MYOGLOBIN - ANVISA Registration 10350840479

Access comprehensive regulatory information for MYOGLOBIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10350840479 and manufactured by BODITECH MED INC.. The registration is held by BIOSYS LTDA with validity until Jun 23, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including HANGZHOU ALLTEST BIOTECH CO. LTD, QINGDAO HIGHTOP BIOTECH CO.,LTD., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10350840479
2 Related Devices
Registration Details
ANVISA Registration Number: 10350840479
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

Famรญlia AFIAS Myoglobin Neo
Risk Class III

Registration Details

10350840479

25351030133202518

02220795000179

Company Information

BODITECH MED INC.
South Korea
PT: CORร‰IA DO SUL

Dates and Status

Jun 23, 2025

23/06/2035

09/18/2025 19:00:01

Famรญlia AFIAS Myoglobin Neo
Risk Class III

Registration Details

10350840479

25351030133202518

02220795000179

Company Information

Dates and Status

Jun 23, 2025

23/06/2035

09/18/2025 19:00:01